MOLECULAR CELLULAR BIOLOGY, Feb. 1988, p. 843-853                                                                   Vol. 8,  2
0270-7306/88/020843-11$02.00/0
Copyright X 1988, American Society Microbiology


      DNA Sequence, Structure, Tyrosine Kinase Activity        Drosophila melanogaster Abelson Proto-Oncogene Homolog
      MARK J. HENKEMEYER, RANDY L. BENNETT, FRANK B. GERTLER, F. MICHAEL HOFFMANN*
             McArdle Laboratory Cancer Research, University Wisconsin, Madison, Wisconsin 53706
                                       Received 30 September 1987/Accepted 16 November 1987

             report molecular characterization Drosophila melanogaster Abelson gene (abl), gene            recessive loss function mutations result lethality pupal stage development. essential gene
           consists 10 exons extending 26 kilobase pairs genomic DNA. DNA sequence encodes protein
           1,520 amino acids strong sequence similarit human c-abl proto-oncogene beginning type
           lb 5' exon extending region essential tyrosine kinase activity. tyrosine kinase
           homologous region expressed Escherichia coli, phosphorylation proteins tyrosine residues            observed antiphosphotyrosine antibody. results abl gene highly conserved
           evolution encodes functional tyrosine protein kinase required Drosophila development.

   Protein tyrosine kinases identified viral          kinase published tyrosine kinase
transforming proteins acutely oncogenic retroviruses (17).           sequences (15). Drosophila sequence called Dash, determined sequences encoding pro-                Drosophila Abelson-src homologous. view teins transduced cellular sequences. classes              extensive similarity Abelson gene reported protein tyrosine kinases described: cyto-              keeping convention letter code plasmic tyrosine kinases src, abl, yes, fgr,               Drosophila genes, suggest Drosophila gene fps-fes members membrane-spanning growth                    called abl.
factor receptor tyrosine kinases, including erbB, fms, ros,               identified mutations Drosophila abl gene neu (16). cell surface receptors encoding tyrosine            failure complement chromosomal deletions kinase activity include receptors insulin platelet-         overlap abl transcription unit rescue derived growth factor (51, 55).                                         mutant phenotypes cloned abl DNA transgenic flies
   Abelson (abl) tyrosine kinase proto-oncogene ex-              (13a). continuation analysis gene, pressed wide variety mammalian cells (54).          genomic structure determined nucleotide level. alternate 5' exons amino termini mouse (1)               addition having sequence similarity mammalian abl alternate 5' exons amino termini humans (45).                genes, Drosophila gene encodes functional protein function alternate processing 5' ends          kinase capable phosphorylating proteins tyrosine res-
genes known;  exons                 idues.
replaced Abelson proto-oncogene activated transforming oncogene Abelson murine leukemia                                   MATERIALS METHODS
retrovirus, human chronic myelogenous leukemia (54),                    DNAs. XDabl-1, Charon 4 clone Canton S flies, human acute lymphocytic leukemias (9).                 isolated low-stringency hybridizations v-abl
activated, altered abl proteins exhibit elevated tyrosine               probe (14). XDashor2 isolated library (provided
kinase activity (7), shown essential           J. Pustell, Harvard University) Oregon R fly DNA transforming activity Abelson murine leuke-             EMB3L 4 vector. X4.8 X4.8.5 Charon 4, clones mia virus (32).                                                         library Canton S DNA, isolated McKeown et al.
   Drosophila melanogaster genes shown                (27) chromosomal walk originating abl. Cloned extensive sequence similarity mammalian              genomic DNAs subcloned pSDL12 -13 (23) avian proto-oncogenes (44). Drosophila homologs                  pTZ18r -19r (Pharmacia, , Piscataway, N.J.) vectors,
clude members tyrosine kinase family (11, 14, 15, 47),           overlapping deletions obtained using ras family (30, 41), epidermal growth factor receptor            DNaseI (21) T4 DNA polymerase (6).
homolog (25), myb homolog (18). Drosophila                       Drosophila cDNAs isolated embryonic genes sevenless (13) wingless (36) originally stud-            pupal XGT10 cDNA libraries (31). libraries probed
ied mutant phenotypes; subsequently              vitro-synthesized RNA derived subcloned
amino acid sequences similar  respec-               genomic fragments. Positives plaque purified used
tively, tyrosine kinase int proto-oncogene sequences.             probe blots cloned DNA spanning Drosophila abl levels spatial distributions transcripts              region. cDNA inserts subcloned pTZ18r number Drosophila genes suggest expres-               pTZ19r.
 sion developmentally controlled associated               Sequence analysis. production single-stranded bac-
proliferating cells terminally differentiated tissues          teriophage induced superinfection plasmid 
(13, 36, 40, 42, 46, 49).                                               taining bacteria helper phage M13ko7 (Pharmacia).
   reported Drosophila amino acid sequence               Phage DNA purified subjected dideoxynucleotide similar kinase domain Abelson tyrosine            sequencing (39) [355]dATP (2). M13 reverse primer
                                                                        (New England BioLabs, , Beverly, Mass.) custom-
  *
      Corresponding author.                                             synthesized oligomers (University Wisconsin Biotechnol-
                                                                  843
 844    HENKEMEYER ET AL.                                                                                    MOL. CELL. BIOL.

ogy Center) used prime sequencing reactions.         mid-log phase (A6. = 0.6 0.7), fusion protein synthe-
Compressed regions resolved replacing deoxygua-          sis induced adding isopropyl-,3-D-thiogalactopy-
nosine deoxyinosine reactions (28). Sequence         ranoside final concentration 1 mM. 2-h
reactions separated 4  acrylamide short (45 35        incubation, 1-ml samples cultures centrifuged,
cm) 2  acrylamide long (115 35 cm) gels containing 7       bacterial pellets suspended 100 ,ul 2x
M urea 0.5x TBE (lx TBE 89 mM Tris, 89 mM boric           sodium dodecyl sulfate sample buffer (20) boiled 5
acid, 2 mM EDTA [pH 8.0]). Gels dried          min. 20-pdl sample loaded lane 10  glass plates autoradiography (10). Analysis     polyacrylamide gel. electrophoresis, proteins sequence data accomplished pro-            electrotransferred nitrocellulose paper (0.45-pum pore
grams (8, 34, 35).                                               size; Schleicher & Schuell, , Keene, N.H.). electro-
   Primer extension. Total embryonic RNA isolated       transfer buffer Towbin et al. (50). Efficiency 0 17-h-old embryos (5). 20-pmol sample gel-purified    protein transfer checked staining nitrocellulose
oligomer (5'-CATTGCCAGTGGGTGGTTGG-3') la-                    filters Ponceau S stain (Sigma Chemical , St. Louis,
beled polynucleotide kinase 0.5 mCi [32P]ATP        Mo.). Blots blocked 2 h room temperature
(3,000 Ci/mmol; Amersham Corp., Arlington Heights, Ill.)         1  Carnation nonfat dry milk phosphate-buffered
(26). Unincorporated nucleotides removed             saline-Tween (PBS-T; 10 mM KH2PO4, 150 mM NaCl,
successive ethanol precipitations 2 M ammonium acetate.       0.05  Tween 20 [pH 7.2]). Blots rinsed time 1-pd sample 5x primer extension buffer (250 mM Tris         PBS-T incubated 0.3 p.g antiphosphotyro-
[pH 8.3], 250 mM KCl, 50 mM MgCl2, 200 mM dithiothrei-           sine (PTyr) antibody ml (52) PBS-T containing 3 
tol) added 0.3 pmol dried kinased primer          fraction V bovine serum albumin (Miles Scientific, Div.
siliconized Eppendorf tube. 100-,ug sample (4 ,ul) total    Miles Laboratories, , Naperville, Ill.) 3 h room
embryonic RNA tRNA  control) added               temperature. 10-min washes 1  dry milk gently mixed. mixture pipetted drawn          PBS-T, blots incubated anti-rabbit immuno-
siliconized 20-pd capillary pipette. pipette sealed      globulin G antibodies conjugated alkaline phosphatase flame placed boiling-water bath 2 min.   (Sigma) 1:1,000 dilution 1  dry milk-PBS-T 1 h.
pipette immediately transferred 60°C water         Blots washed developed Nitro Blue
bath. 1-h hybridization, mixture quickly         Tetrazolium bromochloroindolylphosphate 0.1 M
expelled 5 pR1 reverse transcriptase mix (1 x primer     Tris buffer (pH 9.5) (Kirkegaard Perry Laboratories,
extension buffer, 10 units RNasin, 2 mM deoxynu-         Gaithersburg, Md.) detect immunoreactive proteins.
cleoside triphosphate, 40 U Moloney murine leukemia
virus reverse transcriptase) incubated 37°C 30 min.                             RESULTS
Fresh reverse transcriptase mix (5 ,lI) added incubated 30 min. Preboiled RNase (10 ,ul        Isolation genomic cDNA clones. recombi-
5-mg/ml stock) added incubated 37°C 15 min.       nant clone Drosophila abl gene (ADabl-1) isolated extraction phenol-chloroform, mixture      probing Drosophila genomic DNA libraries low hybrid-
ethanol precipitated 2 M ammonium acetate. exten-         ization stringency v-abl probe Abelson murine
sion products suspended formamide-containing brom-       leukemia virus (14). Overlapping clones isolated phenol blue-xylene cyanol, boiled 3 min, iced,      probes derived isolated fragments subclones resolved 8  acrylamide sequencing gel. DNA               ADabl-1. McKeown et al. (27) used Drosophila abl DNA
sequence reaction kinased primer          probes initiate chromosomal walk Drosophila
loaded gel provide size standards. Gels           gene transformer, generously provided exposed film Cronex Lightning-Plus intensifying      clones X4.8 X4.8.5 (Fig. 1).
screens.                                                            Portions genomic DNA similar v-abl
   Construction bacterial lacZ-abl fusion genes. por-     probe sequenced contain open reading
tions abl gene cloned pUR series         frame encoded putative protein product extensive
bacterial expression vectors (37). pURABLkin             amino acid similarity v-abl protein (15). structed digesting abl cDNA P1 PstI        region genomic DNA detected RNA products PvuII gel isolating 1.4-kilobase fragment. vec-      Northern (RNA) blots ranging size 5.5 6.0
tor, pUR291, cut HindIII, flush end           kilobases (22, 49). Fragments genomic DNA created Klenow fragment DNA polymerase             used screen cDNA libraries, number cDNA vector cut PstI, PstI-PvuII abl        clones isolated embryonic pupal libraries
fragment ligated vector. pURABLcarb             (Fig. 2). cDNAs localized genomic map constructed digesting abl cDNA L PstI, isolating     restriction endonuclease mapping Southern blot analysis 0.9-kilobase fragment, ligating vector       cloned genomic DNA (data shown).
pUR290, previously digested PstI.               DNA sequence exonic structure abl. Drosophila
Plasmids frame fusions detected appear-      abl genomic cDNA clones sequenced sub-
ance novel 170- 155-kilodalton proteins Coomassie      cloning DNAs appropriate vectors creating blue-stained polyacrylamide gels lysates induced         series overlapping deletions. locations se-
Escherichia coli (CSH26) cultures containing pURABLkin           quenced fragments shown Fig. 2. cases, pURABLcarb, respectively.                                    synthetic oligonucleotide primer complementary end
   Immunoblots. Overnight cultures E. coli containing         sequenced region used extend sequence pUR290, pURABLkin, pURABLcarb grown L                gap (arrows beginning dots Fig. 2). gaps
broth containing 50 jig ampicillin ml 50 ,ug       remaining sequence data internal introns 1 streptomycin ml (CSH26 carries streptomycin resis-         2.
tance gene). overnight cultures diluted 1:100       composite sequence genomic cDNA clones
L broth plus ampicillin streptomycin grown        shown Fig. 3. sequence includes 10,343 base pairs
                                                                                                             _
VOL. 8, 1988                                                                                                  D. MELANOGASTER ABELSON TYROSINE KINASE                                                                 845

                          .Cenrtomere

                                                                                        *   *                                                         *

                      H     H                   E H               H       SBH S H E                       E                          ES        E   H           SW~iB
                                                                                                                                                                     B    SB                    E     S SE
                      II                       I                                 II                  ~                                                                                                                                                                                                                  fi        lEII

                                                                                         X 4.8
                                            X 4.8.5                                                                                      X Dab 1

                                                                                                                                                                    XA Dashor77


                                               l               l              l                  l                     l                                                         II
                152       148       144      140      136        132      128    124     120        116       112      108 Kb
   FIG. 1. Restriction map Drosophila abl homolog. overlapping phage inserts containing abl sequences used study shown map. Restriction enzyme sites located map BamHI (B), EcoRI (E), HindlIl (H), Sall (S). Restriction site
polymorphisms Ki,roe,pP chromosome background indicated asterisks. polymorphism Canton S
isolates (XDabl-1, X4.8, X4.8.5) Oregon R isolate (XDashor7) shown 300-bp insertion XDashor7. Hatched boxes
indicate genomic DNA sequenced analysis. Direction transcription left right. Coordinate zero scale position 3LR)st-a27 breakpoint scarlet locus (27). chromosome arm (3L) reverse orientation centromere left telomere right. Kb, Kilobases.


(bp) DNA discontinuity (arrows)                                                         act Goldberg-Hogness TATA box. introns. Including introns, abl transcrip-                                                           CAAAT sequence -95. repeated sequences exist tion unit spans 26 kilobase pairs genomic DNA.                                                              putative promoter including seven copies AAAGC
assignment position introns, exception                                                          repeat regions alternating purine-pyrimidine introns highly conserved kinase domain,                                                               repeats. role sequences function determined sequencing exon junctions                                                             promoter known. open reading frame
cDNA clones. Primer extension embryonic RNA                                                                     beginning exon 1 extending exon 10; encodes used determine transcription initiation point (Fig. 4).                                                         protein 1,520 amino acids. initiation codon position cap site (position + 1 DNA sequence) 39 bp 5'                                                            +97 preceded frame stop codons positions start longest cDNA, P1 (Fig. 3).                                                                   +7, -9, -12, -15, -18.
sequence TAATAA present 25 bp 5' cap site                                                                  compared sizes abl exons derived 
    ,oromwe
                                            IKb

    Gon DNA-.                                                                               0-04            4I-            4-                 *4
                                                                                                                                               -      4       -           -             -    4w         -.
                                                                                                                                                                                                        4       4-U

                                                                                             _   .__*

H                     S         B       H             S                  P                                         _                _
t                                                         etL-.        L
.                     ,     _                         13-SKh
                                                          0.0 VW                                                          'WI-9-




                                   hsgn dDNAFtnN
                            oposke ful                                                                                                  s                                                         -V
                            DNAmmd:                                               5.
                                                                     P1                                 .              .        .       ...




                                                                     PM
                                                                                                                                                                                                  *s
                                                                     G                                                                                                                             3.
                                                                                                                                                                                   =~~~~~
                                                                     d)ASH 1.5
  FIG. 2. Sequencing strategy, location cDNAs, exon organization Drosophila abl. arrows DNA map indicate regions sequenced. Single-stranded phage DNA sequenced annealing standard M13 reverse primer (arrow) custom-synthesized primers (indicated dot) purchased University Wisconsin Biotechnology Center. Open boxes represent 10 abl exons, lines represent introns 5' 3' nontranscribed sequences. map discontinuous intron 1, totals
14.5 kilobases (kb) length. 5' 3' ends shown composite length mRNA, positions translation initiation termination codons. composite mRNA maps cDNA clones isolated pupal (P1 P4Cl) embryonic (L, G, cDash 1.5) libraries. Regions sequenced cDNA clones indicated respective isolates. 5' P1 indicates cDNA contains 5' untranslated sequences, 3' L G indicates poly  tails present cDNAs. splice junctions confirmed sequencing cDNAs introns 3, 4, 5.
 846   HENKEMEYER ET AL.                                                                                                                                          McDL. CELL. BIOL.
                                   - 7 3SccscTJiTcaca
                                          CGG?GtGA             ATT ?TCAA Cr ACGC?ca?CGTATCCTGCCAAG?aSATGc???AAACGACCccaAGCc G?CocACACGA?CAAGT?GGA??CC            -622
       AA??CGA?UsCCTCC AuTOC?GC?GACAAC^ACTACAGA?GAGTACCAI?CCAlCCACCTCAACsaCAGAGCCTATA? CC ACAaJUGCGAACr.TA?ATCCA???GCCC??CAGGGTCAGCC?GCGGATCAATT^AACCGTAKA
                                                                                                                                                                         -472
       AAAACCAGGCAGCSAGAACCUACAGACCAAGGCAliGCCAGACaG         C C    AACSCC^TTCTCAGGCTGTTTTGAGACCCSCCCTCCaCAT GTCACCCAGCCCCTCCCACCTCGCAAGAAG TTTGCCGACAC                  -322
       AACATTTTACCAACATGCTGCAAATTCCAATCATCCTGACGGCCACTAGACAACAAACA?ATAA?TCCCAACCC?CCTTT?CCTCCGTCGTCT?CTTCTGTGTGATGCG?TTCCTCCATCTTTTTTGTCTACTCCAA                         -172
       AACG       CC            TTOCCC AATTAATCTCAAATCAL TAaAAGCAACOWAAATAAT?WAATasa       cAAGGCC        cAAACTTGAAGAAAACAAaAAAACAAAGCAAATAATA                          -22

                                                                    P1 eDNA START                                                   1
                                                                   *+                                                             MstGlyAlaG1nG1nGlyLysaspArqGlyAlaM
       AGTAGTOATAAGCGTaacAAGCTAGAGC                  wu-rcc-
                                                        TTTCTGCGCAAGAGCGAAAAACCACCCAACCCACCCACTGGCAAATGGGCTCACCCAGOrCAAGCAGGGCGCCC                                       130

       sS*rGlyGlyGlyGlyS*rGlyAalProV& lS rCys ldlyL rS-rS rProValAl^SorV lS-rProH1 *Cy*II*S*rS*rSerSerGlyVa rS rAl ProL uGlyGlyGlySerThrL uArgGlyS-rArg        ACT        _SC            TCA GCTGC                = AGCAGCCC:AGTCTCCCS   TCSCtCSCSCACTOCATCCAGTCOCAGCGTCGAGCACGCCCCCCTCGGCGGGCTCCACGCTCCGTGGCTCCCGCA             280
                                                                                                                                                                111
       l-LysS rSerS rS-rClyV lS rGlyS rG1yS-rGlyGlyGlyClyGlyGlyS rGlySerGlyL rGInArgS rGlyGlyHlsLysa pAleakrCysa nProThrV lGlyLouAsnllePh ShrGluH1sksnG
       TCAAGTCCTCGTCCTmcCGTG:cACCCAGGCAGCOGATC=WGGCG
                                                cSAsSToeaTCCG                  TGACCTa .TGCGGcACASCAAGTGCAGTCACCCACC          GTGGGTCTcCATACTTTCACCGAGCATAACG            430
                                                                                                  14.S XS
       GTAAGTTCC?GATTTCGGAACa           CASCCATGCCTAGTAAAGCAAGCT     maCCCaaaC            C     CCTOCTGAAASTGCACTSaCTCTTCATGATATACCAGATTACCATCGGCTACAATTG                50


                                                     113                                              129
                                                   ly?hrLysHlsS.rS.rPbeArqGlyNlsProClyLy&Tyrgils5tkanL.uC
       CCTCTCACC'CAAJATCTTTCTGTTSTTCTGTTCSCTTCAGTCCACCACC        CCI _ 1=    ACTTlCTlACTGS^ASACCCTTJ
                                                                                                   T GTCGCATGAG                                                          730
                  1.2 U

       GsTTCAssTaccaaTaCssTAACTAscTaGax~TACTTTcoTaAcTAGarTACASTAATCOSSWUTTTCTLTACCTTGAGCT                   _         Toc
       TACCC_     TCTU7CT_SC7CC_TC
                                                                                                                                                                        1030
       AGClCC = C^TSSTCTA&TTTTATSlCCO    ST^^TOCAT^^TT _C                    _TCC                                                                                        1130
       TTGCT?TCTCCTACTACCT CAAAAMACGATTTOCAAAATCTC?AkT              -    G                      ATA^AAACACGA                                                             1330
                                                                                                                                                                         1480
                                                                                                                131
                                                                                                            luAlaL.uLouGlnSerkrgProLOuProHisIl?ProAlaGlyS.rThrarqPr
                                                                                                                                                                         1630



                                                                                                                                                                        1710


                                                                                                                                                                        1930
                                        ,V-ABL

       rooL Pb yLsrarlPhl^VluThrClnGlnAlClysPhlnATpSrLCulyCCluLyuL uOlNnClySerVSoroL
                                                                                  u      sluGllyHiolyL-r ullTThrS rVoL*u lu?yrPkl HProLarqInAbsnLyPrThraulPhurL
                TCTlCGT                                                                              TCC7C7CCCaATACCGTCTTTCSCOCSCCGC1_as 2060
                                                                         ACCCC7CCTCCOACCTAGCS;CTTCOC==


                                          309                                                                               311
       *PSrolProGlluurAspGluTpProluL ubVleCskrkpluSyrAtph LysiLysCulyGlyGlyAClnLTuSrGLy
       rGluS.rSerProGlyGInArqS.r1l.o.rL.ukr                                                uV    lTyrGluGlnValTrpLyL uSyrGSyA^snThrVarlAlVly&lThrpLyCluAspH1*Sra
                                                                                                                      gTyEG1uG1yAXYValTyrHL*TyPArgI1000rGluaspP
                                                                                                                                                                        2230




         pSryysV lClyaThrrpV lur roroPhS Tyr
                                          lfPoIL ThrGl CuLMSHri*GysnrSrpSyrH1plyProLI1-rS rAr&GAnlykrgGluThrL^uLuS
                                                                                                                 rSAlCVylAlaLonuouySrPbtAL uVlnlArager                  2380
                                                                                                                                  
       CCCTATC^AGGTCTCTOCACCAGAGCCC?CCACCT^TCTSACATCCCCGSAGTTTCCATTCGCTOTACCC7
                     sr T?K                                                     TCGJUOCCCCTCSTA;SCCUCUCCCTCSCCTCCCTC


                                                                                                                                                                        2530
       rClyuStrTyrProCluClnArgSArnTySrLleuAr      gLTyrGUAnyaeVllAsAnyLeVlyVIA&sPoGyo
                                                                                   W LouCltArgAsphsThrTlyrThrAl-HSArluaGyAP
                                                                               448
       *tAlaLeuLyAskpPh.L.uGluGluAlaAlaIllNstLy.GluNstLysHbgProAsnL.uValGlnL.uxlle
       LyA phrlyyVlPhy pVThrAlnCroluAlyL,"ayPhSrksLyuAl^ClrTuLyuV erHsp1*lrp laProl luly01
                                                                                        CuouplyuIlokbThrTroLeLy
                                                                                                             uSyrPolProTyr rolalanLmu?hTrV lPh P?ro         2680
       AATCCCGTAATGGACCACGAGGG7GC7C?C7WA?TACCAC:mRtATCsTaacGC__                                        ACTATGAAG                                    CSSSO^;cccctC
                   450

                                                                                                                                                                        2830
                                                                                                                                              MAJOR

             GuPoluSPSroAluShrpluAl ClGuysAGTnhrAsnAl-ttALsnAlThSLyLrAyCylyCrSrSrlnPSyrTrClCu SerClyVAI ThrGlyGyaGlyAOlAThrThrThrhrlAlaVlyShrGLyuy Clag       pSertlr
       CJGUTAGCTACCGACATCGGCGCACTACATCACGMCGACCACGCCACOCACGCTGACGCT?
       sCOCATGCACCGAGTscccCGGTasGAAAAcaGGAWCCacacAGsT                  GASCAATt-
                                                                  CCOGC?CT
                                                                     CTCCCCCCA7AC OCCC AA CAC00cMcG       cGccc?cAcc7
                                                                                           ACCAGACGCGCCTAGCGC?CGCTCCTACC?                                               2960


       *rAlLThLyApPh
                   LeuCeLouThrProGlIntVltLy CtelySLysuProGAlGnAVlGlL uThI1 C            afiHmnsPoisIGnIk&erhPoeSr                                                       3130
       SCGOCAC7CCIC7C
             CSaACCGCCCCSAaAGTCCACACGCASACTiGAAAGGG?TT                                          AACGAtCCACCOACaSSCATAGCACCATGCAAGGCCASGTAASCCTTTGCJCT

                 lyv lsthragGluPoPuThetrI-lyerhSbr?luhdLyLtS rThrheSernLuLpPbyLyuaGlys ralGiCNArgkrluhrTr nLysGInGlyL uysGInAlaPrk&roproLysAlSrq                      3280
       AC?CSAGST?TCA?GCCA?TCTTCAGACCGATCCACSTCTCCACCCAACTASC_ACTTCSSCC7CAGCC                                                                                            3430
                                                                                                                                                                        3580
                                                                                                                                        734

                                                                                                                                                                        3730
                                                                                                    ATTATCGATGAATAA7CTC7CCTCGATG?aCG
       ACAGSTAAGCCSACACACTCTCTTATGG?GGA?CGAATCAGiC?T?SCACAA?GTGTAl ==AASC7CATTAGGCAAAtAGSCCAGAhSCCSCCGAGG


                                                   ~~
                                                 73£~
                                                    ~~ ~                     ~~~~~~~~~~~~~~~~~3                                                                         3660



                                                                                                                                                                        4030
       774                                                                                                                                        77£
       ThrSA                                                                                                                                     rL.uL*uSerS*rSerArq
                                                                                                                                                                        4130
                                                                                      604

           GACTCCACTTATCGCGAGGAGGCATCCACCCAACGCCACATOCCATTTCATCGCGACCTCCAGCACGAATGGTAAtCACAAATTAAATCCAACTATTTCAGCCAACCCTCTCACAAGtAACATTCAWAAAATTCCAACCCACCAT                            4330
           ACACACCAAATACGTACACAACAACAACAACACAACAGTCCGTAACACAACaJIAACAAATASGTACCATTGTCAG?CACAACAACCAACACTCAACAACAGCAAACAAACAACaACGTATTCCATTAAGA&ATCGTCCTCCTCCAGTAGT                      4460
           TTTCSTTACGACATCC xiCGAGTATT??G?AAiCCGGAGTCCATAGCGCAAxATCTCCTATTAnASAJACTTA ssGxC.iTSGTTATTGSTTTGTTACT?TTTTTTAATTGTAATTGGTTTGTTACTACTTACAT
                                                                                          AST                                                                                           4630
           AJiGTTTCTGCATTATTGGTTGTTCATTGTGGAAGATCTCTTCATAGC KTTCaSCCGOCGGTSxATTCAILATTCAGaaTTACSAATTCaAATATT STCGATGSCTTTCCT CTT &&ass&LCTCSCAGATCTCTAG                                 4780
           CATTAACATTTTCATTTGATGTTTCTCTAACCATCCCASTTCCACTATTTTGCGT.G&GTTATATTGCTTTCCASSTSCTanATTCSSTT     TTOCC   TATA   CGTGTTTTTtATTTAGTAATTATTTTAACT                                 4930
           ATCATATGGTTTATATCCTTGAAAGTCGTSATTCTTTAATATACSC CTCGSSaAS                                             GSGSCTGTAATTCGATGGATCCTA?ATTACCCAAAiATAGGATGGACTTTAAGAA
                                                                            CTTATCTTGTGSSATCTTAGTTATTTAACCT TGTAGC                                                                      5060
           TATTAAAACTCAATTTAGAAATCAATGaAAACACTASTGTAATGCATCCTTTCAGTSTAACCAG;ATATSTCCiUICAACCTCATTTAATTATAAGTTGATAATTTGGTGTTTTCTAGSTTTTACTCICTCGCAAACATCAACGCACAC                        5230
                              sAACCCATACCCAATccsscaGssGsATGACTAATa
           ATCCCAAGCTGTAGTTcAacccG                                                    AG&TCGGTACTCTTATAAACTCAGTTTTTCAsACCAGATATAARAATTATkTCAGTmatascaGsC?AGATAG?                        5380


                                                                                                                                                       lyL*uAlaArgAspIleA nSerLeuTh
           TTTCCCATCACTGACCATTAATACCACC CACCATCAAAKGT*                      asCAc^TTGAT ITG              CACTGSTTTAC
                                                                                         _ACSCASSGACASCACGG


           rGInArcj?yrkspSerGiu?hrkspProAlaAlakspProaspThrksphl&ThrGlyAspSerLouGluGInSerL*uSerGInValIlekl&kl&ProValThrksaLysfttGlnHisSerL*uHisSerGlyGlyGlyGlyGlyGl
           GCAGCGG?ACGA??CCGAkACAC.k?CCGGCAGCCGkCccGGWAC              12r.'r.'rf-,--AG?C?GGAGCAGACTCTGAOCC                                                                              5630


           yIleGlyProArg3orSerGInGlnHisSerS*rPhoLyskrgProThrGlyTbrProV&lN*tGlyksnkrgGlylAmGluThrkrgGlnSerLyakrq"rGlnL*uHisSerGInAlaProGlyProGlyProProS*rThrGlnpr
           AATAGGTCC                                                                                                                                               Cr-ICCATCAACTCAACC   5830


           oHisHisGlyksnkenGlyV&IV hr2orklaRisProIle?hrValGlykl&LeukxpV&lnotksnValLy*GlnValValksnkrqTyrC.lyThrLouProLyoGlykl&krglleGlykl&TyrLou"pSerLouGluAspSe
           GCkTCkTGGCkAC                                    TGWTGCOC                                                                                   TG=                        AG    5960



          CAG                               TGCTCCT                                 GCCTccr.0c                                                        TCkGGAWAACTCGTCGGGCGGAGTGAC       6130



          CA?GCAAAAC         ?CC                                                                        ICCxICI"-"'-mCP-MMCGGlr?CCAG?AGC?CACCCAAGCGGAG?GCC?CGGGAGTGOCwMAGGAG?CCA        6280


          nProAlaL.ouAlaAanLouGluPhoProProProProLeukspLeuProPr*ProProGluGluPbeGluGlyGlyProProProProProProAlaProGluSerAI&V&lGlnklall*GlnGlnHisLeuHisAl&GlnLouProks
          GCCAGCTCTGOCCAACCTTGAG                                                                                   AA AAA IIAA                   TCCAGCAGCACTTGCATOCCCAGCTGCCAAA      6430


          nAsnGlyksnIleSerAsnGlykanGlyThrksnksnksnk*pSerSergi"snAspValSerAmnlIsAI&ProSerValGloGluklaSerSerArgPhWlyValSorLsuArgLysArqGluProSerThrAsp$*rCyaSerSe
          CAATGGCAACATTACCAATGGAAACGGAACAAACAACAACGACA(;CAGCCACAACGATGTTAOCAACAT                                                                                           TGCAGCTC     6580


          rLAuGlySerProProGlukopLouLys4luLyaLouIleTbrGlulleLy Al&GlyLysAapTbrJa&Pr*AlaSerHisL*uAlaAanGlySerGlyIl*Al&ValValAspProV rLouLauValThrGluL*uAlaGI
          GCTGGGCAGTCC                   AAAAGCT                             MAGGAT     TOCTCCGGCCTCACATCTGGCCAACGGCTMOCCATCGCTGTCGTGGACCCCGTCTCCCTGCTTGTCACCGAACTAGCCGA                6730


           rN*tksnL*uProLysProlProlProGinGinGinGinLysLouThrAonGlyAsnSerThrGlySerGlyPhoLysklaGInL*uLyaLysValGluProLysLysfttSorkl&ProMetProLyskrqThrklaksnThrll*Ii
           GAOCkTGkACCTGCC    DPCeCCOPrar                                                                      kAGAAAG                               khTGCCCAAGCGGACCGCAAATACCkTCkT     6660


           *AspPh LysAlaRisL*LuAr9^rqValAopLyaGluLynGlu rokShrProAaroAl ProA&TrV&lklV aklaknAbSA rCy lynTSTrGlyTrAusLydGlukapGlySerLsLyPhSS
                                                                                                                                                                                        7030

                                                                                                                                   134,
           rGlnAlaNetGlnLysThrGluleLyollekpValThrA*SrAnV lGiuklpalclraloly                   cluclrGYIUIAsPL^clyLyrsArgUrThA
           GCAGGCC                                                                                                                                                                                 ----s                                   c    accAkTGCT
                                                                                                                                               s  __ = _ _                              7160
                                                                                                                                                                                        7330
           CAAGCCCGCC ACCC_ _CA _A_?_------_CGCACATAAACCTCTCCAT                                                                                                      TCAOCACTCTT        7480

                 1351

                                                                                                  TGT                                            TG=                                    7630



          CACGCCTATTOCCAAACTGACCGAACC                                 ATC                                                                     TGAATC.CCATCGCTGGATCTCAGTGGCTGCAGCTGAG    7760


                                                                                                                                                                                        7930

                                                                                 1520

             ACGGCAC
          GGC^                                 CsaT== SCASG                      SA              ACGG S^_
                                                                                                       ----------GScA                                                                   6060
          GTGATCSSGGGCCCCAATG                                                                                                                                           GCGGA           6230
                                                                                                                                                                                        6360
               S_ATTJIc
          CCAAGA GA                                                                          TsSc                            CSTTGa          sTcTA                   Ac     CT    6530
                                                                                                                                                                                        660
                                                                                                                                                                                        6630
                                                                                                                                                                                        6960
                                                                                                                                                                                        9130
                                                                                                             eDNA L cDNA G polyA

          AACCAACTGTAATTATATCTGAT            CAST          TTATCS           ACT_                        _                 ATASlAACASTTTCAA KNGATCGAGACAGGCGT                            9290
                                      ATAS=TTSA"C^TCSOCATSSTASOCCTStCCCSACA= = c1 _TCGAAAATTAAAGACAA                                                                                    9430
          AAATGGGCCAACAC      FTSCUATTTTCSSSCACA c ea c xaas                          _   C ca                                                                                      9560
          GAGAAIZTA=GAT*AAGAA??C 9608
   FIG. 3. Nucleotide sequence predicted amino acid sequence Drosophila abl. Nucleotide residues numbered 5' 3'
direction, + 1 representing mRNA cap site. nucleotide sequence does include entire introns, positions approximate DNA missing indicated arrows. genomic sequence continuous remaining exons. 5' sequence represented cDNA clone (+39) indicated start P1 cDNA. initiation codon, AUG, located nucleotide position +97. predicted 1,520-residue primary amino acid sequence spans 10 exons printed DNA
sequence indicate exon positions. extensive homology amino acid sequence mammalian c-abl sequence used locate landmark positions sequence. homologous location gag-abl fusion junction Abelson murine leukemia virus shown (V-ABL). conserved tyrosine kinase essential domain bracketed TPK. includes conserved 9-amino-acid peptide
(overlined) lysine residue ATP-binding site tyrosine residue (MAJOR) principle target autophosphorylation v-abl gene. 3' untranslated region, sites poly  addition cDNAs L G indicated arrows. putative
polyadenylation sites underlined. Putative mRNA degradation signals, AUUUA motifs, indicated bold underline.
                                                                                                 847
 848     HENKEMEYER ET AL.                                                                                                 MOL. CELL. BIOL.


                                                       GCAAATTCGCAATTGCACCTGAGCGGCCACTAGAACAACA                 -262
                                                       AATCAGATAAATCGCAAACTTCCTTTTTCCTCCGTGCGTG                 -222
                                                       TGTACTTCTGTGTGTGCGTGAGTGTCTCCAATCTTTTTTG                 -1 82
                                                       TCTACTCCAAAAACGCAGAAAGAGAAAGAAAAATGTGTGC                 -142
                                       4- Extension    GTGTGTGTGTGTGAAATAAATTAAAGCAAAGCAAAAGGCA                -102
                                                       AAACGGCAAATAATTGAGCAAAAGGCCAAGAGAGAAGAGT                -62
                                                       TAAAGCTGAAGTATATAACAAGAAAAGCAAAGCAAATAAT -22

                                                       AAGTAGTAGTAGTAAGCGAATAAGCCGTAGCAGCAGGAGC                  19

                                                       CGAGAGAAGAGAGAGAAAAGTGTACAAGTTGTTGTTGCTG                  59

                                                       CGCAAGAGCGAAAAACCACCCAACCACCCACTGGCAAATG                +99




                             
                              '.




                                    JK.Primer
  FIG. 4. Position mRNA cap site. point abl transcription initiation determined primer extension. 32P-labeled
synthetic oligonucleotide annealed total embryonic RNA (+) tRNA (-) extended reverse transcriptase. products separated 8  polyacrylamide gel, contained dideoxy sequencing reaction labeled primer size standards. sense-strand nucleotide sequence shown. location synthetic oligonucleotide indicated asterisks. arrow marks position primer extension product defines nucleotide + 1. translation initiation codon + 97 ATG indicated boldface, putative TATA CAAT boxes positions -25 -95, respectively. repeating units present 250-bp region upstream transcription start site. Stretches alternating purines pyrimidines overlined, AAAGC motif repeated seven times underlined.
DNA sequence data sizes derived Si nuclease                  (exons 10.1 10.5 Table 1). Multiple polyadenylation
mapping reported Telford colleagues (49) (Table 1).               sites unprecedented Drosophila genes. exonic structure derived DNA sequence Fig.               seven polyadenylation sites Drosophila
3 largely consistent Si nuclease mapping. Probes             tropomyosin gene (4). abl sequence searched containing exons used                  consensus polyadenylation sequence AAUAAA, allow-
protection experiments (49). inconsistency lies                  ing base changes number different exons 6 9 cDNA sequence                    polyadenylation signals used nature (3). codon bias analysis (35) genomic sequence indicate                translation stop codon, consensus AAUAAA exons (numbers 7 8) 120 88 bp,                sequences (underlined Fig. 3). Si data predicted single 350-bp exon.                                  close poly  addition occurs produce    intron DNA sequence (348 bp) falls               second fifth mRNA according data Telford
region Si analysis (49) produces RNAs differing              et al. (49). Sequences differ consensus size approximately 350 bp. intron absent              nucleotide (underlined Fig. 3) located close ends independent cDNA clones isolated spanned               transcripts detected S1 nuclease region.  DNA sequence intron                 mapping. sequences present tandem arrays contains open reading frame frame                copies. systems, alternative 3' adenyl-
reading frames exons 9 10. Optional splicing              ation signals efficient AAUAAA sequence;
intron rise different-sized mRNAs                  tandem copies compensate lower effi-
detected Si analysis produce protein products             ciency single copy.
differing 116 amino acids.                                               searched abl sequence consensus
   Si protection experiments Telford et al. (49)              AUUUA, sequence implicated mRNA degra-
indicated different mRNA 3' ends formed                   dation mammalian genes, including proto-onco-
 VOL. 8, 1988                                                                       D. MELANOGASTER ABELSON TYROSINE KINASE                    849

                  TABLE 1. Length exons abl                                   Drosophila sequence searched se-
                         bases                      Length exon         quences using GAP program. amino terminus Exon                   protected                      DNA sequence             predicted Drosophila protein similar                         Si nucleasea                           (bases)              human type lb amino terminus mouse type IV amino
                                                                                    terminus. Drosophila protein contains Gly-Ser-rich
1                           NDb                            429                      insertions region present mamma-
2                           ND                              54
3                            540                           541                      lian proteins.
4                            400                           418                         amino acid sequence similarity low 5                            580                           587                      carboxy-terminal portions Drosophila human
6                            280                           271                      Abelson proteins (amino acids 660 1520 Drosophila
7                            350                           121                      abO. region, alignment contains 28 gaps, 8                             ?                             89                      16  amino acid identity 28  amino acid similarity. 9                           1,650                        1,635                      mouse human amino acid sequences divergent
10.1                          970                          956 (ATTAAA)C            region, 140 amino acids 10.2                        1,190                        1,180 (AATAAA)C            conserved (45). search National Biomedical 
10.3                        1,340                        1,310 (GATAAA)C            search Foundation protein data base conducted, 10.4                        1,740                        1,735 (CATAAA)d
                                                         1,742 (AAT7AA)C            significant sequence similarities 10.5                        2,190                        2,104 (AATAAA)C            genes data base carboxy domains   reference 49.
                                                                                    Drosophila mammalian abl proteins.
  b ND, determined.                                                                Tyrosine kinase activity. extensive sequence similarity
    exons 10 begin splice acceptor junction. different sizes    Drosophila Abelson protein human 10.1 10.5 differences 3' ends exons. sizes      murine c-abl proteins suggests Drosophila abl
shown nearest polyadenylation consensus sequence (shown               protein tyrosine kinase. effort raise
parentheses).                                                                       antisera Drosophila protein, 3-galactosidase-abl fu-
  d length exon 10.4 set position poly  tails cDNAs L G.                                                                   sion proteins expressed E. coli. Phosphor-
                                                                                    ylation proteins measured using anti-PTyr anti-
                                                                                    body kindly provided J. Y. J. Wang (University genes (43). total 16 representatives sequence                           California, San Diego) (52). E. coli does contain detect-  10 copies detected intronic sequences                           able PTyr anti-PTyr, E. coli expressing kinase 6 copies 3' untranslated regions.                         essential domain v-abl contains high levels PTyr (19).
noted Fig. 3 bold underline.                                                   regions Drosophila abl gene cloned    Alignment Drosophia human Abelson genes.                              pUR series expression vectors (Fig. 6). pURABLkin
Genbank data base searched Drosophila abl                              contains tyrosine kinase-homologous region SH2
amino acid sequence using FASTP (24) WordSearch                               region, plus flanking sequences. pURABLcarb contains (8; University Wisconsin Genetics Group).                           portion gene nonconserved carboxy-terminal similar sequences human murine c-abl                          region. immunoblots lysates induced cells
proteins. Alignment predicted Drosophila amino acid                          containing pUR290, pURABLkin, pURABLcarb sequence human sequence performed                             probed high-affinity anti-PTyr, proteins different programs: FASTP (24), homology matrix (34),                           pUR290- pURABLcarb-containing cells PTyr
GAP (29; University Wisconsin Genetics                                  residues. contrast, peptides pURABLkin cell
Group). alignments similar respects.                          lysates reacted anti-PTyr antibody (Fig. 7).    alignment generated GAP shown Fig. 5.                           major phosphorylated protein pURABLkin fusion
program accounted conservative amino acid changes                               protein. protein bands seen blot (12). Overall, Drosophila human abl genes 62                           degradation products fusion protein. fully
amino acid sequence similarity optimized alignment                           confident bacterial proteins phosphorylated.
(including identical conservative amino acids). location tyrosine kinase domain abl proteins                                             DISCUSSION amino-terminal half protein. organization
contrasts src cytoplasmic tyro-                           detailed molecular analysis Drosophila abl gene
sine kinases, kinase domain carboxy                          initiated determine extent similarity 
end protein. region essential protein tyrosine                    tween Drosophila abl sequence mammalian abl
kinase activity, sequences 87  similar 77                               sequences, map entire abl transcriptional unit, identical. boundaries kinase essential region                        determine Drosophila abl protein actually func-
derived alignments vertebrate tyrosine kinase                            tions tyrosine kinase. Drosophila abl amino acid
mains (17). amino-terminal tyrosine kinase                       sequence similar mammalian c-abl sequence
domain second conserved region, SH2 (src homology                          gene. homology Drosoph-  2) domain. 100-amino-acid domain                               ila human c-abl sequences extends cytoplasmic tyrosine protein kinases trans-                          regions previously reported (15). importantly, membrane receptor tyrosine kinases (38). Drosophila                             homologous region extends portion abl human abl sequences 86  similar 78  identical                           protein essential tyrosine kinase activity. SH2 region. strong similarity Dro-                           tyrosine kinase essential domain deduced align-
sophila human Abelson proteins begins 73 amino acids                            ments tyrosine kinases (38) deletion analysis SH2 region extends 24 amino acids                             abl gene measurement tyrosine kinase activity tyrosine kinase essential domain.                                               (32). similarity Drosophila human
   different amino termini detected                          abl amino acid sequences 75  Drosophila amino
mouse c-abl gene human c-abl gene (1, 45).                          acids 187 656, 469-amino-acid domain. conserv-
 850            HENKEMEYER ET AL.                                                                                           MOL. CELL. BIOL.

       1       W§AQQGKDRGRHSGGGGSGAPVSCIGLSSSPVASVSPHCISSSSGVSSAPLGGSTLRGSRIKSSSSGVASGSGSGGGSGSGLSQRSGGHXDARCNP                           100
                                                                                                                                          100
           11            1

       1 MGQQPGKVLGDQR .........................................................................                                       P 15
   101                        SRPLPHIPAGSTRPLFNRIAELQQHQQDSGGLGLQGSSLGGGHSSTTSVFESAHR"SENLLG 200
           TVGLNIFT2HNGT0HSSFRG0PGKY0MAT
            : lIi II11 : ::                            11                                               :1I11111111111
      16 SLPALHFIKGAGKXESSRHGGP.HCWFVEQALQRPVASDFEPQG ...................................... LSEAARINSKENLLA.G 75

   201 PEEDDPQLFVALYDFQAG     QLSLKGEQVRILSYNKSGECEAHSDSGNVGWPSNYVTPLNSLEKHSWYHGPISRNAAEYLLSSGINGSFLVRESES 300
                                                111111:
               1 1:11 11111111 1-1:1 11: 111 :1:1:11      1 IIIII11:II:IIIIIIIIIIII:IIIIIII 111111I11111111'1
      76 PSENDPNIFVALYDFVASGDNTLSITKGEKLRVlGYNHNGENCAQTKNQ.GWVPSNYITPVNSLEKHSWYHGPVSRNAAEYPLSSGINGSFLVRESES 174

   301 SPG4RSISLRYEGRVYHYRISEDP0EAKFNTLAELVHHHSVPHEGHGLITPLLYPAPKQNKPTVFPLSPEPDENEICRTDIMMKHKLGGGQYG
                                                                                                  400
           II:II1IIIIIIII111II1    III: 1I:IIII1I111111      : 1111 1 11111 11111: :11 1 11:'1111 lIlII1
   175     SPSQRSISLRYEGRVYHYRINTASDGKLYVSSESRFNTL&ELVHHHSTV..ADGLITTLHYPAPKRNKPTVYGVSPNYDKnEMERTDITMKHKLGGGQYG 272
   401 EVYEAVW     RYGNTVAVKTLKEDTMALKDFLEEAIMXEMZHPNLVQLIGVCTREPPFYIITEFMSHGNLLDFLRSAGRETLDAVALLYMATQIASGMSYL                            500
                       IIIII11111'                    11:1111:!
           '111111111  11111               III:IIIIIIII:IIIIIIIiIII          11'111:11 :11 11111111 1:1 11
   273 EVYE           IKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLIGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYN&TQISSAMEYL 372
   501     ESRNYIHRDIAARNCLVGDNKLVKVADFGLARLMRDDTYTAHAGAKFPIKTAPEGLAYNKFSTKSDVWAFGVLLWEIATYGMSPYPAIDLTDVYHKLDK                            600
            IIIIIIII1I111 111111111 111 :I11111111111111111:1111111 1111111111111I11111111:11 :11 1:1
   373     EKKNFIHRDLI&RNCLVGENHLVKVADFGLSRLMTGDTYTAHAG&KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDRSQVYELLEK                           472
   601 GYRMERPPGCPPEVYDIMR4CNQWDATDRPTFKSIHHALEHMFQESSITEAVEKQLNATSASSSAPSTSGVATGGGATTTTAASGCASSSSATASLSL 700
       :1I1II1I11I1 I1:IIII :II1      1 1: 1:1111111 1: III:I1'             ::      II            
   473 DYRMKRPEGCPEKVYEIMRACWQWNPSDRPSFAEIHQAFETHFQESSISDEVEKELGKQGVRG ..... AVSTLLQAPELPTKTRTSRRAAEHRDTTDVPE 567
   701 TPQ MGLPGGQALTPNAHHNDPHQQQASTPMSETGSTSTKLSTFSSQGKGNVQMRRTTNKQGKQAPAPPKRTSLLSSSRDSTYREEDPANARCNFIDD 800
        1:    11   ::                          :1 ::II1:             11I11 111              1 :11 1     1
   568 MPH ..SKGQGESDPLDHEPAVSPLLPRKERGPPEGGLNEDERL .. LPKDKKTNL.FSALIKKKKKTAPTPPKAS ........ SSFREMDGQPERRG.... 650

   801     LSTNGL&RDINSLTQRYDS.ETDPAADPDTDATGDSLEQSLSQVIAPVTNKMQHSLHSGGGGGGIGPRSSQQHSSFKRPTGTPVMGNRGLETRQSKRSQ                            899
             ': I      :            :: :                    : :1I1: 1 :        651 .AGEEEGRDISNGALAFTPLDTADPAKSPKPSNGAGVPNG ............... ALRESGGSGFRSPHLWKSSTL .TSSR 715

  900      LHSQAPGPGPPSTQPHHGNNGVVTSAHPITVGALDVHNVKQVVNRYGTLPKGARGAYLDSLEDSSEAAPALPATAPSLPPA. .NGHATPPAARLNPKAS                           997
                      I         :1    :1              1:    1 111::                            11: :
                                                                                                     :1     11:      11
  716 LITGEEEGGGSSSKRFLRSCSVSCVPH .......... GAKDTEWRSVTLPRD ................... LQSTGRQFDSSTFGGHKSEKPALPRKKAG 786

  998 PIPPQQMRSNSSGGYSLNN        KLQRHRTTTEGT HTFSSRAGGSSSSPXRSASGVASGVQPALANLEFPPPPLDLPPPPEEFEGGPPPPPPAP 1097
          :1: 1:                  ::::1I                                          :                                II              :II 1: 1:: 1:'1:
  787 ENRSDQVTRCTVTPPPRLVKKNWEEAADEVFKD ............ INESSPGSSPPNLTPKPLRRQVTVA ........ PASGLPHKEEAWKGSALGTPAAA 866

 1098 ESAVQAI19HLHAQLPNNGNISNGNGTNNNDSSHNDVSNIAPSVEASSRFG.VSLRKREPSTDSCSSLGSPPEDLKEKLITEIKAAGKDTAPASHLANG
                                                                                                      1196
                      : :   11::~~~~~~~                                          1     I1 1      :1 1 1                     11:11    :: I
  867 EPVTPT ......    VRAGSGAPRGTSXGPAESRKSSESPGRDKGKLSKLKPAPPPPPAASAG .KAGGKPSQRPGQEA&G 942
 1197      SGIAVVDPVSLLVTELESNNLPKiPPPQQQQKLTNGNSTGSGFKAQLKKVEP!LSPMPKRTANTIIDFKAHLRRVDKEKEPATP.APAPATVAVANNA                             1295
                 ::           ~~~                                  :1    :1I              1 1:1 :        11                                   11 :11:                     ....... TSLVDAVNSDAAKPSQP.
  943 EAVLGAKTA                                          GEGLKKPVLPATPKPQPA .................                KPSGTPISPAPVPLSTLPSA 1007

 1296 NCNTTGTINRKEDGSKKSwIQKTEIKIDVTNSNDAGAAGEGDLGKRSTDDEEQSHTEGLGSGGGSADMTQSLYEQKPQIQQKPAVPHPTKLT 1395
         :     ::    ::    :: 1      1: 11    1:                           1 1: 1:
 1008 SSALAG    DQPSSTAFIPLISTRVSLRKTRQPPEPASGAITKGW ........................ LSTELC .................... 1058
                      .....




 1396 IYATPIA1TEPASSASST4ISESILELVGLEGSLKHPVIAGS9W0LSDILHNSCVIFAENGMPPHSKFQFELVRVEQSQHLR               1490
                   1 1: 11:   1:                   1:: 1: 1:1           ::     I1I11: ::1       1
 1059 ...........LAISGNSEQMSHSAV ................ LEAGKNLYTFCVSYV .... DSIQQNRNKAFREAINKLENNLRELQICPAS 1121
 1491 .SAGSKNVQDNERLVAEVGQSLRQISNALNR 1520
                      11    :1:   1:::11::  1122 AGSGPAATQDFSKLLS.... SVKEISDIVQR 1148
  FIG. 5. Comparison predicted amino acid sequences Drosophila human abl proteins. Drosophila abl amino acid
sequence  line) aligned human c-abl amino acid sequence (lower line) program GAP (University Wisconsin
Genetics Group). program set gap weight 3.75 length weight 0. Conservative amino acid changes scored using modified Dayhoff table amino acid substitutions (12). Identical amino acids indicated solid bar, conservative
amino acid changes shown dots. type lb human c-abl amino terminus (45) shown gave better alignment Drosophila sequence did alternate human c-abl amino terminus. SH2 region cytoplasmic tyrosine kinases (38) aligns amino acids 260 359 Drosophila abl sequence. tyrosine kinase essential domain (17) aligns amino acids 381 632 Drosophila abl sequence.
 VOL. 8, 1988                                                           D. MELANOGASTER ABELSON TYROSINE KINASE                              851

                                                            Kbp
                                                                                                                                                                                     -2
                                                                                       c                                            
                  SH2      TPK                                                                                                         l
                                                                                        v
 aml                 _                                                       0)                           0)                cDNA

                Poti     ,0
                                     II
                                 Pvull     Pstl   v~Pstl                       gr                             CMJ
                                                                                                                  cc
                                                                                                                         M
                                                                                                                                                           /stl                                                                                       n.L       nCL       IC
                       Pvull                      Pot


         Pstl              (Pvull)                 PotI         neti                                  lB OKd


                                                                                                       116


                                                                                                      ' 84



                                                                                                        58


                                                                                                        48.5

                                                                                 Ponseau S                         anti-PTyr
                                                                          FIG. 7. Tyrosine kinase activity abl kinase domain ex-
                                                                        pressed E. coli. Immunoblot analysis performed ly-
                                                                        sates cells containing expression plasmids pUR290,
                                                                        pURABLcarb, pURABLkin. Similar amounts protein                                                                         loaded lane, indicated staining proteins                                                                         nitrocellulose filter Ponseau S, shown left panel.                                                                         major proteins lanes pUR290, pURABLcarb, pURABLkin
                                                                        ,-galactosidase (116 kilodaltons), pURABLcarb fusion pro-
  FIG. 6. Construction abl expression plasmids pURABLkin             tein (155 kilodaltons), pURABLkin fusion protein (170 pURABLcarb. abl cDNA shown line                 kilodaltons), respectively. right panel shows immunoblot                                                                         similarly prepared nitrocellulose blot anti-PTyr antibody.
composite overlapping abl cDNA clones 10 exons        Note proteins pURABLkin lane detected. indicated 10 boxes. positions putative initiation     major phosphorylated protein pURABLkin fusion protein, termination codons indicated cDNA. cDNA           peptides react anti-PTyr
fragment used constructing pURABLkin contains SH2             antibody degradation products fusion protein. Kd, Kilo-
gion (conserved cytoplasmic tyrosine kinases) tyro-       daltons.
sine kinase essential domain (TPK); cDNA fragment used pURABLcarb derived carboxy-terminal domain unknown function. Restriction sites used construction     kinase providing hydrophobic anchor membranes
plasmids shown; sites destroyed cloning procedure        (54).
shown parentheses. abl sequences expressed fusions           evidence multiple amino termini lacZ using inducible promoter Lac operon. Kbp,       reported mouse human abl genes (1, 45).
Kilobase pairs.                                                          ruled existence                                                                         amino termini Drosophila abl gene. primer
                                                                        extension experiment used map site transcriptional
ative amino acids included calculations,            initiation, hybridized oligonucleotide primer exon 1
similarity 85  469-amino-acid domain.                detected alternative addition sequences essential tyrosine kinase activ-          exons. isolation cDNA clones Si
ity, large region homology spans sequence               nuclease mapping additional primer extension experi-
conserved cytoplasmic tyrosine kinases, SH2              ments used determine exons domain (38).                                                            amino termini exist Drosophila abl gene.
   amino acid sequence homology Drosoph-                   carboxy half abl protein conserved
ila abl gene human abl gene begins 12              D. melanogaster mammals. function amino acids proteins. initial homology               domain protein known. required soon interrupted glycine- serine-rich insertions          v-abl-induced transformation fibroblasts lymphoid cells Drosophila sequence. amino termini align              (33). Rat-1 cells, sequences carboxy Drosophila sequence compared type lb                    domain v-abl toxic cells spontaneous
human type IV murine amino termini. specific                 deletions region selected (56). function,  mammalian amino termini               sequence homology poor, similarities
known. provide N-terminal glycine, does               carboxy portions Drosophila mam-
Drosophila sequence, site myristylation,            malian abl genes. sizes protein domains carboxy case v-src v-abl proteins. Myristylation           kinase domains similar: 864 amino acids D. affect intracellular localization abl tyrosine         melanogaster 620 amino acids humans.  852     HENKEMEYER ET AL.                                                                                               MOL. CELL. BIOL.

carboxy domain human c-abl sequence, region                    sources enriched ribonuclease. Biochemistry 18: amino acids 800 1000 17.5  proline (45).                5294-5299.
Drosophila sequence 8  proline overall, region              6. Dale, R. M. K., B.  McClure, J. P. Houchins. 1985. amino acids 950 1150 14  proline. region               rapid single-stranded cloning strategy producing sequential
                                                                          series overlapping clones use DNA sequencing: appli- highest proline content approximately aligns                  cation sequencing corn mitochondrial 18 S rDNA. Plas-
proline-rich region human sequence.                                mid 13:31-40.
   expressing kinase essential domain bacteria,           7. Davis, R. L., J. B. Konopka, 0. N. Witte. 1985. Activation
showed homology mammalian abl                    c-abl oncogene viral transduction chromosomal Drosophila abl proteins extends enzymatic                    translocation generates altered c-abl proteins similar activity. domain expressed E. coli, exten-               vitro kinase properties. Mol. Cell. Biol. 5:204-213.
sive phosphorylation proteins tyrosine residues              8. Devereux, J., P. Haeberli, 0. Smithies. 1984. comprehen-
observed. similar result observed kinase              sive set sequence analysis programs VAX. Nucleic
portion v-abl protein (19). examples suggest              Acids Res. 12:387-395.
                                                                       9. Erikson, J., C.  Griffin,  ar-Rushdi, M. Valtieri, J. Hoxie, J. activity bacteria good indication normal               Finan, B. S. Emanuel, G. Rovera, P. C. Nowell, C. M.
activity proteins. Deletions v-abl protein            Croce. 1986. Heterogeneity chromosome 22 breakpoint abolish kinase activity E. coli abolish transform-            Philadelphia-positive (Phi) acute lymphocytic leukemia. Proc.
ing activity v-abl protein NIH 3T3 cells (32).                  Natl. Acad. Sci. USA 83:1807-1811.
Temperature-sensitive mutations kinase activity             10. Garoff, H., W. Ansorge. 1981. Improvements DNA
v-abl expressed bacteria temperature sensitive            sequencing gels. Anal. Biochem. 115:450-457.
focus-forming ability mammalian cells (19).                        11. Gregory, R. J., K. L. Kammermeyer, W. S. Vincent Ill,    Drosophila sequence specifically               S. G. Wadsworth. 1987. Primary sequence developmental
associated tyrosine kinase activity. Previous indica-                expression novel Drosophila melanogaster src gene. Mol.
                                                                          Cell. Biol. 7:2119-2127.
tions tyrosine kinase activity D. melanogaster include          12. Gribskov, M., R. R. Burgess. 1986. Sigma factors E.
phosphorylation tumor-bearing rabbit antisera tyrosine              coli, B. subtilis, phage SPOl, phage T4 homologous
residues proteins Drosophila embryos (47)                     proteins. Nucleic Acids Res. 14:6745-6763.
detection PTyr Drosophila embryos anti-PTyr                13. Hafen, E., K. Basler, J.-E. Edstroem, G. M. Rubin. 1987.
antibodies (48).                                                          Sevenless, cell-specific homeotic gene Drosophila, encodes
   Protein kinases regulate broad variety biochemical                putative transmembrane receptor tyrosine kinase
processes eucaryotic cells (16). involvement tyro-              domain. Science 236:55-63.
sine protein kinase activity transforming oncoproteins         13a.Henkemeyer, M. J., F. B. Gertler, W. Goodman, F. M.
growth factor receptors leads suspect                     Hoffmann. 1987. Drosophila Abelsen proto-oncogene ho-
                                                                          molog: identification mutant alleles pleiotropic
tyrosine kinases modulate processes critical regulation            effects late development. Cell 51:821-828. cell growth differentiation  understand         14. Hoffman-Falk, H., P. Einat, B.  Shilo, F. M. Hoffmann. processes individual tyrosine kinases                   1983. Drosophila melanogaster DNA clones homologous modulate  begun genetic analysis                    vertebrate oncogenes: evidence common ancestor Drosophila tyrosine kinases. shown Dro-                  src abl cellular genes. Cell 32:589-598.
sophila abl gene required proper development               15. Hoffmann, F. M., L. D. Fresco, H. Hoffman-Falk, B. 
viability D. melanogaster (13a). results presented                 Shilo. 1983. Nucleotide sequences Drosophila src abl Drosophila abl gene tyrosine kinase               homologs: conservation variability src family onco- amino acid sequence similarity biochemical                    genes. Cell 35:393-401.
activity.                                                             16. Hunter, T. 1987. thousand protein kinases. Cell
                                                                          50:823-829.
                                                                      17. Hunter, T., J.  Cooper. 1985. Protein-tyrosine kinases.
                      ACKNOWLEDGMENTS                                     Annu. Rev. Biochem. 54:897-930.
  dedicate research memory Christine  Phelan.      18. Katzen,  L., T. B. Kornberg, J. M. Bishop. 1985. Isolation
thank J. Y. J. Wang (University California, San Diego)             proto-oncogene c-myb D. melanogaster. Cell
providing anti-PTyr antibodies.                                       41:449-456.
  work funded American Cancer Society grant NP483         19. Kipreos, E. T., G. J. Lee, J. Y. J. Wang. 1987. Isolation F.M.H., Cancer Center support grant CA07175 National          temperature-sensitive tyrosine kinase mutants v-abl onco-
Cancer Institute McArdle Laboratory, predoctoral train-        gene screening antibodies phosphotyrosine. Proc.
ing grant CA09135 National Cancer Institute support       Natl. Acad. Sci. USA 84:1345-1349.
M.J.H. R.L.B.                                                     20. Laemmli, U. K. 1970. Cleavage structural proteins                                                                           assembly head bacteriophage T4. Nature (London)
                       LITERATURE CITED                                   227:680-685.
 1. Ben-Neriah, Y.,  Bernards, M. Paskind, G. Q. Daley, D.      21. Laughon, , M. P. Scott. 1984. Sequence Drosophila
    Baltimore. 1986. Alternative 5' exons c-abl mRNA. Cell 44:         segmentation gene: protein structure homology DNA-
    577-586.                                                              binding proteins. Nature (London) 310:25-31.
 2. Biggin, M. D., T. J. Gibson, G. F. Hong. 1983. Buffer         22. Lev, , N. Leibovitz, 0. Segev, B.  Shilo. 1984. Expres-
    gradient gels "S label aid rapid DNA sequence            sion src abl cellular oncogenes development     determination. Proc. Natl. Acad. Sci. USA 80:3963-3 5.                Drosophila melanogaster. Mol. Cell. Biol. 4:982-984.
 3. Birnsteil, M. L., M. Busslinger, K. Strub. 1985. Transcrip-   23. Levinson, , D. Silver, B. Seed. 1984. Minimal size plas-
    tion termination 3' processing: end site! Cell          mids containing M13 origin production single-stranded
    41:349-359.                                                           transducing particles. J. Mol. Appl. Genet. 2:507-517.
 4. Boardman, M., G. S. Basi, R. V. Storti. 1985. Multiple        24. Lipman, D. J., W. R. Pearson. 1985. Rapid sensitive
    polyadenylation sites Drosophila tropomyosin gene            protein similarity searches. Science 227:1435-1441.
    used generate functional mRNAs. Nucleic Acids Res.             25. Livneh, E., L. Glazer, D. Segal, J. Schlessinger, B.  Shio.
    13:1763-1776.                                                          1985. Drosophila EGF receptor gene homolog: conserva-
 5. Chirgwin, J. M.,  E. Przybyla, R. J. MacDonald, W. J.           tion hormone binding kinase domains. Cell
    Rutter. 1979. Isolation biologically active ribonucleic acid       40:599-607.
 VOL. 8, 1988                                                            D. MELANOGASTER ABELSON TYROSINE KINASE                              853

26. Maniatis, T., E. F. Fritsch, J. Sambrook. 1982. Molecular              Drosophila melanogaster ras transcripts development.
    cloning: laboratory manual. Cold Spring Harbor Laboratory,               Mol. Cell. Biol. 6:2241-2248.
    Cold Spring Harbor, N.Y.                                             43.   Shaw, G., R. Kamen. 1986. conserved AU sequence 27. McKeown, M., J. M. Belote, B. S. Baker. 1987. molecular              3' untranslated region GM-CSF mRNA mediates selec-
    analysis transformer, gene Drosophila melanogaster            tive mRNA degradation. Cell 46:659-667.
    controls female sexual differentiation. Cell 48:489-499.             44.   Shilo, B.  1987. Proto-oncogenes Drosophila melanogaster.
28. Mills, D. R., F. R. Kramer. 1979. Structure-independent                Trends Genet. 3:69-72.
    nucleotide sequence analysis. Proc. Natl. Acad. Sci. USA             45.   Shtivelman, E., B. Lifshitz, R. P. Gale, B.  Roe, E.
    76:2232-2235.                                                              Canaani. 1986. Alternative splicing RNAs transcribed 29. Needleman, S. B., C. D. Wunsch. 1970. general method                 human abl gene ber-abl fused gene. Cell
    applicable search similarities amino acid                47:277-284.
    sequence proteins. J. Mol. Biol. 48:443-453.                  46.   Simon, M. , B. Drees, T. Kornberg, J. M. Bishop. 1985.
30. Neuman-Silberberg, F. S., E. Schejter, F. M. Hoffmann,                 nucleotide sequence tissue-specific expression     B.  Shilo. 1984. Drosophila ras oncogenes: structure             Drosophila c-src. Cell 42:831-840.
    nucleotide sequence. Cell 37:1027-1033.                              47.   Simon, M. , T. B. Kornberg, J. M. Bishop. 1983. 31. Poole, S. J., L. M. Kauvar, B. Drees, T. Kornberg. 1985.               loci related src oncogene tyrosine-specific protein
    engrailed locus Drosophila: structure analysis                kinase activity Drosophila. Nature (London) 302:837-839.
    embryonic transcript. Cell 40:37-43.                                 48.   Sullivan, W. 1987. Independence offushi tarazu expression 32. Prywes, R., J. G. Foulkes, D. Baltimore. 1985. minimal             respect cellular density Drosophila embryos. Nature
    transforming region v-abl segment encoding protein-              (London) 327:164-167.
    tyrosine kinase. J. Virol. 54:114-122.                               49.   Telford, J., J. Burckhardt, B. Butler, V. Pirrotta. 1985.
33. Prywes, R., J. G. Foulkes, N. Rosenberg, D. Baltimore.                 Alternative processing developmental control tran-
    1983. Sequences MuLV protein needed fibroblast                scripts Drosophila abl oncogene homologue. EMBO J.
    lymphoid cell transformation. Cell 34:569-579.                         4:2609-2615.
34. Pustell, J., F. C. Kafatos. 1982. high speed, high capacity    50.   Towbin, H., T. Staehelin, J. Gordon. 1979. Electrophoretic
    homology matrix: zooming SV40 polyoma. Nucleic                 transfer proteins polyacrylamide gels nitrocellulose
    Acids Res. 10:4765-4782.                                                   sheets: procedure applications. Proc. Natl. Acad. Sci.
35. Pustell, J., F. C. Kafatos. 1984. convenient adaptable           USA 76:43504354.
    package programs DNA protein sequence            51.    lrich, , J. R. Beil, E. Y. Chen, R. Herrera, L. M. Petruzzelli,
    management, analysis, homology determination. Nucleic                  T. J. Dull,  Gray, L. Coussens, Y.-C. Liao, M. Tsubokawa, 
    Acids Res. 12:643-655.                                                     Mason, P. H. Seeburg, C. Grunfeld, 0. M. Rosen, J. Rama-
                                                                               chandran. 1985. Human insuli